Black Diamond Therapeutics, Inc. Profile Avatar - Palmy Investing

Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic …

Biotechnology
US, Cambridge [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Black Diamond Therapeutics, Inc. (BDTX) to it's peer group.

Peer Group
RVMD PASG ALEC FIXX HARP TCRR STOK BCEL Compare Together
Loading...
End of BDTX's Analysis
CIK: 1701541 CUSIP: 09203E105 ISIN: US09203E1055 LEI: - UEI: -
Secondary Listings
BDTX has no secondary listings inside our databases.